Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2019

Open Access 01-08-2019 | Original Article

Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study

Authors: Ertao Jia, Hongling Geng, Qingping Liu, Yuya Xiao, Yanying Zhang, Jingjing Xie, Luhe Zhang, Xia Qiu, Li Zhong, Min Xiao, Jianyong Zhang

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2019

Login to get access

Abstract

Objective

To investigate cardiac manifestations and the risk factors in Han Chinese patients with systemic lupus erythematosus (SLE).

Methods

Seven hundred fifty SLE patients who were hospitalized at our department were recruited in the present study. The patients were divided into two groups—those with or without cardiac manifestations. Cardiac manifestations in those SLE patients, such as pericarditis, myocarditis, heart valve disease, arrhythmia, were analyzed. The risk and protective factors of cardiac diseases in patients with SLE, as well as the predictors of mortality, were assessed, respectively.

Results

In all 750 SLE patients, there were 339 (45.20%) patients suffered from one or more cardiac manifestations, involving pericarditis in 9.5%, myocarditis in 5.7%, heart valve disease in 15.6%, arrhythmia in 16.67%, and cardiovascular diseases (CVD) in 14%. 15.7% of SLE patients were accompanied with pulmonary arterial hypertension (PAH), of which 13.7% were mild, 1.2% were moderate, and 0.8% were severe. No significant differences were found between the two groups in age, disease duration, gender, antibody, and Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). The incidence of pericarditis, heart valve disease, arrhythmia, and PAH was positively correlated with age. The incidence of arrhythmia, CVD, and PAH was correlated with SLEDAI. PAH and myocarditis were the risk factors of mortality in SLE patients with disease duration ≤ 10 years (P = 0.034 and 0.001, respectively).

Conclusion

Cardiac involvement is common in Han Chinese SLE patients and associated with age and disease activity. PAH and myocarditis are the risk factors of mortality in SLE.
Literature
3.
go back to reference Pirro M, Stingeni L, Vaudo G, Mannarino MR, Ministrini S, Vonella M, Hansel K, Bagaglia F, Alaeddin A, Lisi P, Mannarino E (2015) Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis. Eur J Prev Cardiol 22:1027–1035. https://doi.org/10.1177/2047487314538858 CrossRefPubMed Pirro M, Stingeni L, Vaudo G, Mannarino MR, Ministrini S, Vonella M, Hansel K, Bagaglia F, Alaeddin A, Lisi P, Mannarino E (2015) Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis. Eur J Prev Cardiol 22:1027–1035. https://​doi.​org/​10.​1177/​2047487314538858​ CrossRefPubMed
6.
go back to reference Garcia MA, Alarcon GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, Gentiletti S, Caeiro F, Sato EI, Borba EF, Brenol JCT, Massardo L, Molina-Restrepo JF, Vasquez G, Guibert-Toledano M, Barile-Fabris L, Amigo MC, Huerta-Yanez GF, Cucho-Venegas JM, Chacon-Diaz R, Pons-Estel BA, on behalf of the Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL) (2014) Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort. Rheumatology (Oxford) 53:1431–1438. https://doi.org/10.1093/rheumatology/keu011 CrossRef Garcia MA, Alarcon GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, Gentiletti S, Caeiro F, Sato EI, Borba EF, Brenol JCT, Massardo L, Molina-Restrepo JF, Vasquez G, Guibert-Toledano M, Barile-Fabris L, Amigo MC, Huerta-Yanez GF, Cucho-Venegas JM, Chacon-Diaz R, Pons-Estel BA, on behalf of the Grupo Latino Americano de Estudio del Lupus Eritematoso (GLADEL) (2014) Primary cardiac disease in systemic lupus erythematosus patients: protective and risk factors--data from a multi-ethnic Latin American cohort. Rheumatology (Oxford) 53:1431–1438. https://​doi.​org/​10.​1093/​rheumatology/​keu011 CrossRef
9.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Austin A, Bell A, Bloch DA, Corey PN, Decker JL, Esdaile J, Fries JF, Ginzler EM, Goldsmith CH, Hochberg MC, Jones JV, Riche NGHL, Liang MH, Lockshin MD, Muenz LR, Sackett DL, Schur PH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, Austin A, Bell A, Bloch DA, Corey PN, Decker JL, Esdaile J, Fries JF, Ginzler EM, Goldsmith CH, Hochberg MC, Jones JV, Riche NGHL, Liang MH, Lockshin MD, Muenz LR, Sackett DL, Schur PH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed
10.
go back to reference Fois E, Le Guern V, Dupuy A et al (2010) Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol 28:836–841PubMed Fois E, Le Guern V, Dupuy A et al (2010) Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol 28:836–841PubMed
11.
go back to reference Lazzerini PE, Capecchi PL, Guideri F, Bellisai F, Selvi E, Acampa M, Costa A, Maggio R, Garcia-Gonzalez E, Bisogno S, Morozzi G, Galeazzi M, Laghi-Pasini F (2007) Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol 100:1029–1034. https://doi.org/10.1016/j.amjcard.2007.04.048 CrossRefPubMed Lazzerini PE, Capecchi PL, Guideri F, Bellisai F, Selvi E, Acampa M, Costa A, Maggio R, Garcia-Gonzalez E, Bisogno S, Morozzi G, Galeazzi M, Laghi-Pasini F (2007) Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease. Am J Cardiol 100:1029–1034. https://​doi.​org/​10.​1016/​j.​amjcard.​2007.​04.​048 CrossRefPubMed
12.
go back to reference Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, Galeazzi M, Marcolongo R, Laghi-Pasini F (2004) Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 50:1248–1252. https://doi.org/10.1002/art.20130 CrossRefPubMed Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G, Galeazzi M, Marcolongo R, Laghi-Pasini F (2004) Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 50:1248–1252. https://​doi.​org/​10.​1002/​art.​20130 CrossRefPubMed
16.
go back to reference Falcao CA, Alves IC, Chahade WH et al (2002) Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus. Arq Bras Cardiol 79:285–291CrossRefPubMed Falcao CA, Alves IC, Chahade WH et al (2002) Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus. Arq Bras Cardiol 79:285–291CrossRefPubMed
17.
go back to reference Gentile R, Lagana B, Tubani L et al (2000) Assessment of echocardiographic abnormalities in patients with systemic lupus erythematosus: correlation with levels of antiphospholipid antibodies. Ital Heart J 1:487–492PubMed Gentile R, Lagana B, Tubani L et al (2000) Assessment of echocardiographic abnormalities in patients with systemic lupus erythematosus: correlation with levels of antiphospholipid antibodies. Ital Heart J 1:487–492PubMed
19.
go back to reference Perez-Villa F, Font J, Azqueta M, Espinosa G, Pare C, Cervera R, Reverter JC, Ingelmo M, Sanz G (2005) Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow-up study. Arthritis Rheum 53:460–467. https://doi.org/10.1002/art.21162 CrossRefPubMed Perez-Villa F, Font J, Azqueta M, Espinosa G, Pare C, Cervera R, Reverter JC, Ingelmo M, Sanz G (2005) Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow-up study. Arthritis Rheum 53:460–467. https://​doi.​org/​10.​1002/​art.​21162 CrossRefPubMed
21.
go back to reference Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH (1992) Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 20:1127–1134CrossRefPubMed Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH (1992) Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 20:1127–1134CrossRefPubMed
27.
go back to reference Quismorio FP Jr (1980) Immune complexes in the pericardial fluid in systemic lupus erythematosus. Arch Intern Med 140:112–114CrossRefPubMed Quismorio FP Jr (1980) Immune complexes in the pericardial fluid in systemic lupus erythematosus. Arch Intern Med 140:112–114CrossRefPubMed
29.
go back to reference Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger RD, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337CrossRefPubMed Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, Berger RD, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337CrossRefPubMed
30.
go back to reference Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, D’Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145:408–415CrossRefPubMed Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jansen-McWilliams L, D’Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145:408–415CrossRefPubMed
33.
go back to reference Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hié M, Hervier B, Costedoat-Chalumeau N, Mazodier K, Ebbo M, Cluzel P, Cordel N, Ribes D, Chastre J, Schleinitz N, Veit V, Piette JC, Harlé JR, Combes A, Amoura Z (2017) Lupus myocarditis: initial presentation and long-term outcomes in a multicentric series of 29 patients. J Rheumatol 44:24–32. https://doi.org/10.3899/jrheum.160493 CrossRefPubMed Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hié M, Hervier B, Costedoat-Chalumeau N, Mazodier K, Ebbo M, Cluzel P, Cordel N, Ribes D, Chastre J, Schleinitz N, Veit V, Piette JC, Harlé JR, Combes A, Amoura Z (2017) Lupus myocarditis: initial presentation and long-term outcomes in a multicentric series of 29 patients. J Rheumatol 44:24–32. https://​doi.​org/​10.​3899/​jrheum.​160493 CrossRefPubMed
34.
go back to reference Frustaci A, Gentiloni N, Caldarulo M (1996) Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 109:282–284CrossRefPubMed Frustaci A, Gentiloni N, Caldarulo M (1996) Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 109:282–284CrossRefPubMed
35.
go back to reference Ueda T, Mizushige K, Aoyama T, Tokuda M, Kiyomoto H, Matsuo H (2000) Echocardiographic observation of acute myocarditis with systemic lupus erythematosus. Jpn Circ J 64:144–146CrossRefPubMed Ueda T, Mizushige K, Aoyama T, Tokuda M, Kiyomoto H, Matsuo H (2000) Echocardiographic observation of acute myocarditis with systemic lupus erythematosus. Jpn Circ J 64:144–146CrossRefPubMed
36.
go back to reference Tamburino C, Fiore CE, Foti R, Salomone E, di Paola R, Grimaldi DR (1989) Endomyocardial biopsy in diagnosis and management of cardiovascular manifestations of systemic lupus erythematosus (SLE). Clin Rheumatol 8:108–112CrossRefPubMed Tamburino C, Fiore CE, Foti R, Salomone E, di Paola R, Grimaldi DR (1989) Endomyocardial biopsy in diagnosis and management of cardiovascular manifestations of systemic lupus erythematosus (SLE). Clin Rheumatol 8:108–112CrossRefPubMed
37.
go back to reference Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238–240CrossRefPubMed Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238–240CrossRefPubMed
38.
go back to reference Wang H, Guo X, Lai J, Wang Q, Tian Z, Liu Y, Li M, Zhao J, Zeng X, Fang Q (2016) Predictors of health-related quality of life in patients with systemic lupus erythematosus associated pulmonary arterial hypertension. Clin Exp Rheumatol 34:291–295PubMed Wang H, Guo X, Lai J, Wang Q, Tian Z, Liu Y, Li M, Zhao J, Zeng X, Fang Q (2016) Predictors of health-related quality of life in patients with systemic lupus erythematosus associated pulmonary arterial hypertension. Clin Exp Rheumatol 34:291–295PubMed
Metadata
Title
Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study
Authors
Ertao Jia
Hongling Geng
Qingping Liu
Yuya Xiao
Yanying Zhang
Jingjing Xie
Luhe Zhang
Xia Qiu
Li Zhong
Min Xiao
Jianyong Zhang
Publication date
01-08-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1934-7

Other articles of this Issue 3/2019

Irish Journal of Medical Science (1971 -) 3/2019 Go to the issue